GLP-1 Limits Adipocyte Inflammation and Its Low Circulating Pre-Operative Concentrations Predict Worse Type 2 Diabetes Remission after Bariatric Surgery in Obese Patients.
Maitane IzaguirreJavier Gómez-AmbrosiAmaia RodríguezBeatriz RamírezSara BecerrilVíctor ValentíRafael MoncadaXabier UnamunoCamilo SilvaMagdalena de la HigueraJavier SalvadorIgnacio MonrealGema FrühbeckVictoria CatalánPublished in: Journal of clinical medicine (2019)
Our data indicate that GLP-1 may contribute to glycemic control and exert a role in T2D remission after RYGB. GLP-1 is also involved in limiting inflammation in human visceral adipocytes.
Keyphrases
- glycemic control
- type diabetes
- obese patients
- insulin resistance
- roux en y gastric bypass
- bariatric surgery
- weight loss
- oxidative stress
- adipose tissue
- blood glucose
- gastric bypass
- disease activity
- endothelial cells
- cardiovascular disease
- high fat diet induced
- ulcerative colitis
- skeletal muscle
- metabolic syndrome
- rheumatoid arthritis
- induced pluripotent stem cells
- fatty acid
- systemic lupus erythematosus
- pluripotent stem cells
- machine learning